1. Tindall BJ. Names at the rank of class, subclass and order, their typification and current status: Supplementary information to Opinion 79. Judicial Commission of the International Committee
on Systematics of Prokaryotes. Int J Syst Evol Microbiol 2014;64: 3599–3602.
2. Thomas F. Bacillus species and related genera other than bacillus anthracis. In: Bennet EJ, Dolin R, Blaser MJ (eds). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious
Diseases, 9th edition. Philadelphia, PA: Elsevier; 2020:2570-2574e2.
3. Logan NA, Hoffmaster AR, Shadomy SV, Stauffer KE. Bacillus and other aerobic endospore-forming bacteria. In:Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW
(eds). Manual of Clinical Microbiology. Vol 1. 10th edition. Washington DC: ASM Press American Society for Microbiology; 2011: 381-402.
4. Enosi Tuipulotu D, Mathur A, Ngo C, Man SM. Bacillus cereus: Epidemiology, Virulence Factors, and Host-Pathogen Interactions. TrendsMicrobiol 2021;29(5):458-471.
5. Dinç G. Bacillus anthracis. İçinde: Sarıgüzel Mutlu F (ed). Gıda Kaynaklı Bakteri Enfeksiyonları, Gıda Kaynaklı Enfeksiyonlar, Kayseri, Erciyes Üniversitesi Yayınları No:214; 2022.
6. Eşel D, Doğanay M. Klinik ve çevre örneklerden Bacillus anthracis izolasyon ve identifikasyonu. İnfeksiyon Dergisi 2002; 16 (1): 1-10.
7. Turnbull P and WHO Anthrax Working Group. Anthrax in humans and animals. Fourth edition. Geneva: World Health Organization 2008.
8. Doganay M, Demiraslan H. Human anthrax as a re-emerging disease. Recent Pat Antiinfect Drug Discov 2015;10(1):10-29.
9. Doganay M, Metan G. Human anthrax in Turkey from 1990 to 2007. Vector Borne Zoonotic Dis 2009; 9(2): 131-140.
10. Doganay M. Anthrax. In: Cohen J, Powderly WG, Opal SM (Eds). Infectious Diseases. 3rd editon, China: Mosby-Elsevier, 2010:1257-1261.
11. Özkurt Z, Parlak M, Taştan R, et al. Anthrax in Eastern Turkey, 1992-2004. Emerging Infectious Diseases 2005; 11:1939-1941.
12. Carus WS. Bioterrorism and biocrimes:the illicit use of biological agents in the 20th century. http://www.ndu.edu/centercounter/pro-lif_publications.htm; 2001.
13. Doganay M, Dinç G, Kutmanova A, Baillie L. Human Anthrax: Update of the Diagnosis and Treatment. Diagnostics, 2023; 13 (1056): 1-13.
14. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Eng J Med 1999; 341: 815-826.
15. Drysdale M, Bourgogne A, Hilsenbeck SG, Koehler TM. atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB. J Bacteriol 2004; 186: 307-315.
16. Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis. Curr Op in Microbiol 2004; 7:19-2.
17. Kaya A, Tasyaran MA, Erol S, Ozkurt Z. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002; 21: 258-261.
18. Demirdağ K, Özden M, Saral Y, Kalkan A, Kilic SS, Ozdarendeli A.Cutaneous anthrax in adults: a review of 25 cases in the Eastern Anatolian Region of Turkey. Infection 2003; 31: 327-330.
19. Doganay M. Ingestional (oral route/enteric) anthrax: Is it a problem in Turkey? FLORA 2009; 14:97-104.
20. Sirisanthana T, Brown EA. Anthrax of the gastrointestinal tract. Emerg Infect Dis 2002; 8: 649-651.
21. Metan G, Uysal B, Coskun R, Percin D, Doganay M. Anthrax meningoencephalitis: a case report and review of Turkish literature.[Article in Turkish]. Mikrobiyol Bul. 2009 43(4):671-676.
22. Kutmanova A, Doganay M, Zholdoshev S. Human anthrax in Kyrgyz Republic: Epidemiology and clinical features. J Infect Public Health 2020; 13: 1161–1165.
23. Hendricks K, Person MK, Bradley JS, Mongkolrattanothai T, Hupert N, Eichacker P et al. Clinical features of patients hospitalized for all routes of Anthrax, 1880–2018: A Systematic Review.
Clin Infect Dis 2022;75 (Suppl. 3):341–353.
24. Inglesby TV, O’Toole T, Henderson DA, et al. Anthrax as a biological weapon, updated recommendations for management. J Amer Med Assoc 2002; 287: 2236-2252.
25. Tomaso H, Bartling C, Al Dahouk S, Hagen RM, Scholz HC, Beyer W et al. Growth characteristics of Bacillus anthracis compared to other Bacillus spp. on the selective nutrient media Anthrax
Blood Agar and Cereus Ident Agar. Syst Appl Microbiol 2006; 29: 24–28.
26. Abshire TG, Brown JE, Ezzell JW. Production and validation of the use of gamma phage for identification of Bacillus anthracis. J Clin Microbiol 2005; 43: 4780–4788.
27. Metan G, Doganay M. The antimicrobial susceptibility of Bacillus anthracis isolated from human cases: a review of the Turkish literature. Turkiye Klinikleri J Med Sci 2009;29(1):229-235.
28. Kayabas U, Karahocagil MK, Ozkurt Z, et. al. Naturally occurring cutaneous anthrax: antibiotic treatment and outcome. Chemotherapy 2012;58(1):34-43
29. Esel D, Doganay M, Sumerkan B. antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Int J Antimicrob Agents 2003; 22: 70-72.
30. Harirchi S, Sar T, Ramezani M, Aliyu H, Etemadifar Z, Nojoumi SA, Yazdian F, Awasthi MK, Taherzadeh MJ. Bacillales: From Taxonomy to Biotechnological and Industrial Perspectives.
Microorganisms 2022;10(12):2355.
31. Tuazon CU, Yu VL, Weber R, Raoult, D. Bacillus species. Infect Dis Antimicrobial Agents 2010, http://www.antimicrobe.org/b82.asp.
32. Celandroni F, Salvetti S, Gueye SA, et al. Identification and pathogenic potential of clinical Bacillus and Paenibacillus isolates. PLoS One 2016;11:e0152831.
33. Pauker VI, Thoma BR, Grass G, Bleichert P, Hanczaruk M, Zöller L , et al. Improved discrimination of Bacillus anthracis from closely related species in the Bacillus cereus Sensu Lato group
based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol 2018; 56, e01900–e01917.
34. Harwood CR, Mouillon JM, Pohl S, Arnau J. Secondary metabolite production and the safety of industrially important members of the Bacillus subtilis group. FEMS Microbiol Rev 2018; 42:
721–738.
35. Bottone EJ. Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev 2010;23(2):382-98.
36. Brouland JP, Sala N, Tusgul S, Rebecchini C, Kovari E. Bacillus cereus bacteremia with central nervous system involvement: A neuropathological study. Clin Neuropathol 2018; 37(1):22-27.
37. Dietrich R, Jessberger N, Ehling-Schulz M, Märtlbauer E, Granum PE. The Food Poisoning Toxins of Bacillus cereus. Toxins (Basel) 2021;13(2):98.
38. Kubota N, Kobayashi J, Kasai A, Nasuno M, Murai T, Minami K, Ohta M. Detection of Bacillus cereus as a causative agent of emetic food poisoning by an unconventional culture procedure.
J Infect Chemother 2022;28(11):1575-1577.
39. Kuroki R, Kawakami K, Qin L, Kaji C, Watanabe K, Kimura Y, et al. Nosocomial bacteremia caused by biofilm-forming Bacillus cereus and Bacillus thuringiensis. Intern. Med 2009;48:791–
796.
40. Drobniewski FA. Bacillus cereus and related species. Clin Microbiol Rev 1993;6(4):324-38.
41. UK Standards for Microbiology Investigations, Identification of Bacillus species, Issued by the Standards Unit, Public Health England,Bacteriology – Identification, ID 9, Issue no: 3.1, Issue
date: 04.04.18, Page: 1-27. https://assets.publishing.service.gov.uk/media/5ac4e7cc40f0b60a4e1b0e7a/ID_9i3.1.pdf
42. Jovanovic J, Ornelis VFM, Madder A, Rajkovic A. Bacillus cereus food intoxication and toxicoinfection. Compr Rev Food Sci Food Saf 2021;20(4):3719-3761.
43. Kopel AC, Carvounis PE, Holz ER. Bacillus cereus endophthalmitis following intravitreal bevacizumab injection. Ophthalm Surg Lasers Imaging 2008;39:153–154.
44. Ikeda M, Yagihara Y, Okazaki M, et al. Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections. Ann Clin Microbiol Antimicrob 2015;14:43–49.